Novo A/S »

Bridgebio Oncology Therapeut shares owned by Novo A/S

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Novo A/S

Quarter filed Position value Share count Share price at filing
2025-09-30 $23M 2.0M 11.58

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Asml Holding N V N Y Registry Shs (ASML)
Mirum Pharmaceuticals (MIRM)
Edgewise Therapeutics (EWTX)
salesforce (CRM)
Merus N V (MRUS)
Crinetics Pharmaceuticals In (CRNX)
Miragen Therapeutics (VRDN)
Alibaba Group Hldg Sponsored Ads (BABA)
Zenas Biopharma (ZBIO)
Pharvaris N V (PHVS)
Recursion Pharmaceuticals In Cl A (RXRX)
Arrivent Biopharma (AVBP)
BioMarin Pharmaceutical (BMRN)

View all positions for Novo A/S

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut